Europe Animal Health Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The market encompasses veterinary pharmaceuticals, biologicals, parasiticides, diagnostics, medicated feed additives and ancillary services supplied to livestock producers, veterinarians and pet owners across European countries. It is closely tied to Europe's roughly EUR 7.9 billion in annual animal-medicines sales reported by the regional industry association, which also documents more than 260 manufacturing SMEs, over 110 research-driven companies and employment exceeding 52,000 people. Demand is sustained by Europe's large livestock inventories, high per-capita pet ownership, and comprehensive veterinary infrastructure.

• •2025 market value estimated at USD 17.46 billion, with a projected CAGR of roughly 6.66%
• •Europe accounts for about one-quarter of global animal-health sales
• •Sector supports more than 52,000 jobs across the EU and UK

Rising disposable incomes and the humanization of pets are pushing higher per-animal spend on preventive and specialty care, while intensification of dairy, poultry and swine production drives demand for vaccines and performance products. Regulatory momentum behind antimicrobial stewardship is accelerating the shift from shared antibiotics to species-specific vaccines, diagnostics and alternatives, expanding addressable revenue. Cross-border supply chains, increased veterinary service availability and rising zoonotic-disease preparedness further reinforce consumption of animal-health solutions.

• •Expanding companion-animal population and premiumization of pet care
• •Livestock intensification and biosecurity investments in dairy, poultry and swine
• •Tightening EU rules on antibiotic use favoring vaccines, diagnostics and alternatives

By product, pharmaceuticals and biologicals together dominate revenue, with parasiticides, anti-infectives, anti-inflammatories and feed additives as principal subcategories, while diagnostics and complementary care are expanding faster than the average. By animal type, farm animals historically represent the largest share, but companion animals are the fastest-growing segment as urban pet ownership rises. Geographically, Western Europe leads in absolute value through Germany, France, the United Kingdom, Spain and Italy, while Central and Eastern European countries are posting higher growth as veterinary infrastructure modernizes.

• •Pharmaceuticals and vaccines remain the largest product categories
• •Companion-animal segment is growing faster than livestock animal health
• •Germany, France and the UK are top revenue contributors; CEE markets are accelerating

What are the recent trends and outlook?

Key structural trends include accelerating vaccine innovation, growth of preventive and wellness regimens, expansion of in-clinic diagnostics, and increasing investment in digital tools such as telemedicine, wearables and data platforms for livestock monitoring. Sustainability, reduced antibiotic use and one-health initiatives connecting animal, human and environmental health are reshaping product pipelines and regulatory expectations. With a projected mid-to-high single-digit CAGR through the early 2030s, the outlook points to continued consolidation, deeper companion-animal penetration in CEE and Southern Europe, and rapid uptake of advanced biologics and diagnostics.

• •Rising adoption of vaccines, preventive care and point-of-need diagnostics
• •Digital and data-driven animal-health solutions expanding across both companion and farm segments
• •Continued M&A activity as multinationals and regional players broaden product portfolios